Suchergebnisse - (Person:"Spalluto, Giampiero")

PubPharm (6)

1

Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems

enthalten in: European journal of medicinal chemistry | 2021

von Grieco, I. | Bissaro, M. | Tiz, D. | +11

2

A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition

enthalten in: ChemMedChem | 2019

von Redenti, S. | Marcovich, I. | De Vita, T. | +13

3

5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors

enthalten in: European journal of medicinal chemistry | 2016

von Federico, S. | Ciancetta, A. | Porta, N. | +6

4

Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists

enthalten in: Journal of chemical information and modeling | 2013

von Bacilieri, M. | Ciancetta, A. | Paoletta, S. | +9

5

Synthesis and biological evaluation of a new series of 1,2,4-triazolo[1,5-a]-1,3,5-triazines as human A(2A) adenosine receptor antagonists with improved water solubility

enthalten in: Journal of medicinal chemistry | 2011

von Federico, S. | Paoletta, S. | Cheong, S. | +9

6

Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists : A preliminary inspection of ligand-receptor recognition process

enthalten in: Bioorganic & medicinal chemistry | 2010

von Pastorin, G. | Federico, S. | Paoletta, S. | +8

1
[1]